4565 — Nxera Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Nxera Pharma Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,375	40,008	60,173	66,557	49,381
Net Total Accounts Receivable
Net Total Receivables	3,689	1,359	2,208	2,520	7,163
Total Inventory
Total Other Current Assets
Total Current Assets	19,563	42,018	62,808	69,942	65,112
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,120	3,824	3,817	3,791	7,900
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	56,680	76,465	96,985	99,417	157,198
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,303	2,985	7,191	4,092	17,185
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	11,605	24,084	39,517	41,481	90,388
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	45,075	52,381	57,468	57,936	66,810
Total Liabilities & Shareholders' Equity	56,680	76,465	96,985	99,417	157,198
Total Common Shares Outstanding